Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Waiting again ...

<< Previous

Bullboard Posts

Next >>

Comment by jeffm34on May 14, 2021 10:55am

91 Views

Post# 33203199

RE:Waiting again ...

And another day when everything on the board is green except for TH of course. Even CYDY is up 10% with the latest news there being 2 more investor class action lawsuits getting underway

longterm56 wrote:
Here we are ... waiting again for the next big announcement ... and probably followed with even greater dissappointment. Does anyone want to guess as to when we hear about Nash or a Phase 1 update?

-LT